Psychedelic Drugs Market Trends and Segments Forecast To 2030
The report " Psychedelic Drugs Market by Drugs (Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine (Ecstasy), Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Etamine, Ayahuasca, Salvia, Psilocybin, Others), by Application (Resistant depression, panic disorder, post-traumatic stress disorder, Opiate Addiction, Others), by End User (Hospitals, Homecare, Specialty Clinics, Others), - Global Forecasts to 2030" The global Psychedelic Drugs Market is projected to reach USD 553.9 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 38.8% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=284375 Competitive Dashboard: The prominent key players operating in the global Psychedelic Drugs Market are Roche Holding AG Pfizer Inc. The Emmes Company COMPASS Group plc Merck & Co. Inc. AstraZeneca PLC AbbVie Inc. Mylan N.V. Alkermes plc Dr. Reddy’s Laboratories ...